Datavault AI Inc. current report, 17 May 2024

Business Context and Reporting Period

This Form 8-K was filed by WiSA Technologies, Inc. (trading symbol: WISA) on May 17, 2024. The report details the closing of a registered direct offering and a concurrent private placement of warrants. Note: The request metadata referenced "Datavault AI Inc.," but the filing text explicitly identifies the registrant as WiSA Technologies, Inc.

Key Financial Metrics and Transaction Details

  • Gross Proceeds: Approximately $2.4 million.
  • Shares Issued: 675,000 shares of Common Stock in a registered direct offering.
  • Offering Price: $3.61 per share.
  • Warrants Issued: Warrants exercisable for up to 675,000 shares of Common Stock.
  • Warrant Exercise Price: $3.48 per share.
  • Placement Agent Fees: 8.0% of gross proceeds plus $50,000 in expense reimbursement.
  • Financial Statements: This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics; it reports a specific capital raise event.

Material Changes and Agreements

The Company entered into a Securities Purchase Agreement dated May 15, 2024, resulting in the issuance of equity and warrants. Key contractual obligations include:

  • Lock-up Period: The Company is restricted from issuing or selling Common Stock or convertible securities for 30 days post-closing, unless required to satisfy Nasdaq listing requirements.
  • Variable Rate Transaction Restriction: A six-month restriction on issuing securities that would constitute a Variable Rate Transaction.
  • Registration Rights: The Company must file a Form S-1 registration statement for the resale of Warrant Shares by June 14, 2024, and use commercially reasonable efforts to have it effective within 90 days.
  • Stockholder Approval: A stockholder meeting must be held by September 30, 2024, to approve the "alternative cashless exercise" feature of the warrants.

Outlook, Risks, and Contingencies

The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard contractual restrictions noted above. The primary contingency is the requirement to maintain Nasdaq listing standards, which may necessitate future financing prior to the expiration of the lock-up period.

Investor Verification Checklist

  • Verify the exact net proceeds after deducting the 8.0% placement fee and $50,000 expense reimbursement.
  • Confirm the status of the Form S-1 registration statement for warrant shares by the June 14, 2024 deadline.
  • Monitor the Company's stock price relative to the $3.48 warrant exercise price to assess potential dilution.
  • Check for the scheduling of the stockholder meeting required by September 30, 2024, to approve the alternative cashless exercise feature.
  • Review the Company's recent financial statements (e.g., 10-Q or 10-K) to understand the impact of this $2.4 million raise on overall liquidity, as this 8-K does not provide balance sheet data.